You prove my point in another post of mine @Mom88. Biotechs have been sold down horrendously over the last few years and will always be able to raise money if they have viable IP. I can see Osteopore is just one of many biotechs which may rise substially in the future once their products are approved.
OSX Price at posting:
52.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)